Congenital Cytomegalovirus (CMV) Infection
The constellation of microcephaly, ventriculomegaly, intracerebral calcifications, and hepatomegaly is classic for congenital cytomegalovirus (CMV) infection.
Clinical Presentation
This tetrad of findings represents symptomatic congenital CMV disease, which occurs in 10-15% of infected newborns 1. The neurological manifestations (microcephaly, ventriculomegaly, and periventricular calcifications) combined with hepatomegaly are pathognomonic features that distinguish CMV from other congenital infections.
Key Distinguishing Features
Periventricular calcifications are the hallmark neuroimaging finding in congenital CMV 2. This distribution pattern differs from:
- Toxoplasmosis: randomly distributed brain calcifications
- Zika virus: similar findings but with more prominent brain atrophy and cortical surface smoothness
The calcifications in CMV arise from viral targeting of periventricular germinal matrix zones and result from osteogenic reprogramming of infected cells, particularly pericytes 3.
Neuroimaging Patterns
Beyond the classic findings, additional neuroimaging abnormalities frequently seen in symptomatic CMV include 4, 5:
- Ventriculomegaly (most common finding - 78% of cases)
- White matter T2/FLAIR signal abnormalities
- Periventricular pseudocysts
- Lissencephaly-pachygyria spectrum (severe migrational defects) 6
- Intraventricular synechia
- Cerebellar lesions
Clinical Significance and Outcomes
Over 50% of symptomatic infants will develop long-term disabilities including 1:
- Sensorineural hearing loss (>40% of symptomatic cases)
- Intellectual disability
- Vision loss
- Cerebral palsy
Critical Pitfall
Maternal preconceptional immunity does not exclude severe fetal CMV infection. Secondary CMV infection can cause identical severe fetal sequelae despite documented maternal immunity 7. When sonographic findings suggest fetal CMV infection, amniocentesis for PCR testing should be performed regardless of maternal serology results.
Diagnostic Approach
When encountering this clinical presentation:
- Confirm CMV infection via urine PCR or CMV-specific IgM in the newborn
- Obtain comprehensive neuroimaging - MRI is superior to CT for defining the extent of gyral and white matter abnormalities 6
- Assess for hepatosplenomegaly (present in 89% of symptomatic cases) 4
- Evaluate for chorioretinitis (44% of cases) 4
- Document hearing status immediately, as CMV accounts for 13-20% of all childhood-onset sensorineural hearing loss 1
The mean age at diagnosis is often delayed (3.5 months) 4, but early identification is critical to enable timely antiviral intervention and prevent unnecessary additional testing.